News

Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and ...
IV, a leading provider of mobile IV therapy in Metro Detroit, is proud to announce the launch of its new Take-Home B12 Kit, designed to support wellness and energy maintenance between in-home IV ...
Compared to the IV infusion of the blockbuster cancer drug Keytruda, subcutaneous Keytruda can cut the time spent in ...
While manufacturers of FDA-approved injectable pentobarbital are warning states not to use the sedative in executions, some ...
Merck’s new formulation of the mega-blockbuster Keytruda, made in collaboration with Alteogen, could help to keep the drug’s patent cliff at bay.
Subcutaneous pembrolizumab reduces time demands for both the patient and clinician, all while providing a consistent efficacy and safety profile with IV pembrolizumab.
Lawyers for a Florida man on death row are seeking to halt his execution set for next week, arguing that his obesity could lead to a botched lethal injection.
Merck released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA ...
The data showed that when given to patients with a type of lung cancer in tandem with chemotherapy, a two-minute injection was as effective as receiving it intravenously (IV) plus chemotherapy.
Trends & Forecast 2022-2032The global IV infusion gravity bags market is experiencing remarkable growth, fueled by the increasing need for efficient fluid delivery systems in healthcare settings.
The National Pension Commission has lamented the limited availability of investable instruments that currently meet the ...